Honglei Jin
- Cancer Research top 5%
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 10
- Molecular Biology top 10%
- RNA modifications and cancer 15
- Ubiquitin and proteasome pathways 10
- RNA Research and Splicing 7
- Circular RNAs in diseases 5
- Geriatrics and Gerontology top 10%
-
- Peptidase Inhibition and Analysis 4
-
- Autophagy in Disease and Therapy 9
- Co-authors
- Chuanshu HuangHaishan HuangJingxia LiJunlan ZhuGuosong JiangXue‐Ru WuDongyun ZhangChao Huang
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Honglei Jin
43 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 467
- Molecular Biology 898
- Geriatrics and Gerontology 29
- Oncology 182
- Epidemiology 225
Countries citing papers authored by Honglei Jin
This map shows the geographic impact of Honglei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglei Jin more than expected).
Fields of papers citing papers by Honglei Jin
This network shows the impact of papers produced by Honglei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglei Jin. The network helps show where Honglei Jin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Honglei Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 13 | |
| 7 | 2021 | 12 | |
| 8 | 2019 | 17 | |
| 9 | 2019 | 21 | |
| 10 | 2019 | 8 | |
| 11 | 2019 | 46 | |
| 12 | 2018 | 38 | |
| 13 | 2018 | 15 | |
| 14 | 2018 | 29 | |
| 15 | 2018 | 34 | |
| 16 | 2017 | 33 | |
| 17 | 2017 | 52 | |
| 18 | 2017 | 14 | |
| 19 | 2016 | 59 | |
| 20 | 2015 | 54 |
About Honglei Jin
Honglei Jin is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), MicroRNA in disease regulation (10 papers), Ubiquitin and proteasome pathways (10 papers), Cancer-related molecular mechanisms research (10 papers), Autophagy in Disease and Therapy (9 papers), RNA Research and Splicing (7 papers), Circular RNAs in diseases (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Cancer Research (467 citations), Molecular Biology (898 citations) and Geriatrics and Gerontology (29 citations). Honglei Jin has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Chuanshu Huang, Haishan Huang, Jingxia Li, Junlan Zhu, Guosong Jiang, Xue‐Ru Wu, Dongyun Zhang, Chao Huang, Jiheng Xu and Zhongxian Tian. Their work appears in journals such as Journal of Biological Chemistry, Oncogene and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.